German software magnate sinks fortune into biotech

German software magnate Dietmar Hopp, who founded SAP, has been putting money into biotechnology over the past few years. He invested $20 million into Cytonet seven years ago to develop liver cells as a substitute for transplants. But he's sunk €320 million into a total of 15 biotech companies, making him the biggest investor in Germany's biotech industry. And he has ambitious plans to grow them into major players in the biotech world.

- read the article on Hopp from Spiegel Online

Suggested Articles

Novartis is forging ahead with the development of spartalizumab in "many, many other indications" despite the setback.

Chi-Med has detailed plans to seek approval from the FDA later this year in part on the strength of data from Chinese phase 3 trial.

The clamor for more transparency from the leading pandemic vaccine contenders has been getting louder.